Clinical Observation of Three-dimensional Conformal Radiotherapy of MM50 Combined with Docetaxol in Patients with Advanced Non-small Cell Lung Cancer

Dang Shengqiang,Cui Lichun,Wang Cuiyu,Xu Shicheng
DOI: https://doi.org/10.3969/j.issn.1009-0959.2011.09.030
2011-01-01
Abstract:Objective:To evaluate clinic effecacy and toxicity of MM50 low split-dimensional conformal radiation therapy combined with docetaxel chemotherapy in the treatment of advanced non-small cell lung cancer.Methods:The lesions of advanced non-small cell lung cancer(PhaseⅢ) confirmed by histology and cytology were located by CT simulation and treatmented by MM50 low split three-dimensional conformal radiation therapy(9-11F of 5Gy/F,qod,3f/w)combined with chemotherapy treatment (docetaxel,ivdrip,25mg/m2)in 52 patients.Results:The short-term effective rate of primary lesions,squamous cell carcinoma, adenocarcinoma and other types carcinoma of pulmonary was respectively 88.46%(46/52),93.33%(28/30),85.0%(17/20) and 50.0% (1/2).The acute toxicity is mainly gastrointestinal reactions.Mild and moderateesophagitis,bone marrow suppression and mild local radiation pneumonitis,but the patients after treatmented can tolerated this toxicity.Conclusion:The treatment program that MM50 low split three-dimendional conformal rediation therapy combined with docetaxel chemotherapy not only insignificantly increased acute toxicity but also increased the short-term effective rate in the treatment of advanced non-small cell lung cancer.
What problem does this paper attempt to address?